StocksTelegraph
S&P 500NASDAQDOWRUSSELL
NYSE · PHR·Healthcare

Phreesia, Inc. Stock Analysis & AI Score

Market Open
$10.04
Prev Close
Market Cap
Day Range
52W Range
P/E
EPS (TTM)
Volume
Avg —
Beta
46
ST Score
45.9/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees
CEO
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date
Website
Country
ExchangeNYSE

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

PHR
45.9out of 100
Grade C+

Phreesia, Inc. (PHR) holds an ST Score of 45.9 out of 100 (C+), with its strongest factor being Growth (A+) and its weakest Sentiment (F). Analysts rate PHR Buy across 26 ratings with a $12.00 average price target (+0.2% vs the current $10.04).

Strongest
GrowthA+
Weakest
SentimentF
All factor grades
  • GrowthA+
  • ProfitabilityA
  • Financial StrengthC+
  • ValuationC
  • ForecastC
  • MomentumD+
  • SentimentF
  • Piotroski4/9
Score methodology
Press Releases

Contact

PHR stock: frequently asked questions

What is PHR's ST Score?

Phreesia, Inc. (PHR) has an ST Score of 45.9 out of 100, an overall grade of C+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is PHR a buy, sell, or hold?

Wall Street's consensus rating on PHR is Buy based on 26 analyst ratings. Our own ST Score grades it C+ (45.9/100). This is data, not investment advice — always do your own research.

What is PHR's valuation grade?

Phreesia, Inc. (PHR) earns a valuation grade of C, measured against Medical - Healthcare Information Services peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is PHR's growth grade?

Phreesia, Inc. (PHR) earns a growth grade of A+, measured against Medical - Healthcare Information Services peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is PHR's profitability grade?

Phreesia, Inc. (PHR) earns a profitability grade of A, measured against Medical - Healthcare Information Services peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is PHR's financial strength grade?

Phreesia, Inc. (PHR) earns a financial strength grade of C+, measured against Medical - Healthcare Information Services peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for PHR?

The average analyst price target for Phreesia, Inc. (PHR) is $12.00 from 26 analysts, which is +0.2% versus the recent price of $10.04.

What is PHR's Piotroski score?

Phreesia, Inc. (PHR) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.